PDF Chinese firm recalls heart drug as US, EU raise concerns
Chinese firm recalls heart drug as US, EU
raise concerns
18 July 2018
The Chinese manufacturer of a widely used blood since the warnings first emerged.
pressure medication said it had launched a global
recall after US and European regulators warned of The company did not answer AFP calls seeking
contamination by a cancer-causing impurity.
comment.
The European Medicines Agency (EMA) first
? 2018 AFP
issued an alert on July 5 over supplies of the active
ingredient valsartan produced by Zhejiang Huahai
Pharmaceutical Company, based in eastern China
and listed on Shanghai's stock exchange.
The US Food and Drug Administration (FDA) issued a similar notice about a week later.
Both have warned of the presence of Nnitrosodimethylamine (NDMA), which is believed to potentially cause cancer through long-term use.
In a series of pronouncements over the past week, Huahai said last Friday that it had moved to suspend supply and had begun a recall.
Valsartan is a generic drug mainly used for treatment of high blood pressure and congestive heart failure.
The EMA has said there is "no immediate risk and patients taking valsartan are advised not to stop their treatments" unless advised by doctors.
Several US companies had already begun voluntarily recalling products containing Huahai's valsartan after the FDA statement.
The FDA said not all products containing valsartan were being recalled in the United States.
"The presence of NDMA was unexpected and is thought to be related to changes in the way the active substance was manufactured," it said.
Both the FDA and EMA are further investigating.
Huahai's stock has dropped more than 10 percent
1 / 2
APA citation: Chinese firm recalls heart drug as US, EU raise concerns (2018, July 18) retrieved 11 November 2022 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
Powered by TCPDF ()
2 / 2
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- pdf your 2019 prescription drug list
- pdf resources for searching california laws and regulations
- pdf aurobindo pharma recall of valsartan containing products
- pdf news state of ohio board of pharmacy
- pdf fda recalls heart medication valsartan citing cancer concerns
- pdf a prescription for investing in health care prices and
- pdf montelukast tablets by camber pharmaceuticals recall due to
- pdf news kentucky board of pharmacy
- pdf news louisiana board of pharmacy